Caring for People’s Health as a Trusted Partner
STADA Thornton & Ross is focused on a three-pillar strategy consisting of consumer healthcare products, generics, and specialty pharmaceuticals.
Caring for customers since 1922, we’re now proud to support Britain’s wellbeing in multiple settings, including consumer healthcare, hospital, primary care, pharmacy and homecare.
We’re proud of our continued UK success. Year-on-year growth has been consistent, and 2023 sales totalled £219 million, with a 14% increase in turnover and 34% growth in net profit.
Our company is part of the STADA Group - STADA Arzneimittel AG | STADA - a leading global manufacturer of high-quality pharmaceuticals. As of December 2023, STADA employed 11,466 people worldwide.
Consumer Healthcare
We are one of UK's fastest-growing, leading producers of consumer healthcare products, owning trusted brands such as Covonia®, Savlon®, Hedrin®, Nizoral® Cetraben® and Zoflora®. In addition, with our proven Generics and Specialty medicines, we also support a sustainable and cost-efficient NHS, widening patient access to effective treatments.
Generics and Specialty
With our proven Generics and Specialty medicines, we also support a sustainable and cost-efficient NHS, widening patient access to effective treatments.
Our portfolio ranges across therapeutic areas including dermatology, respiratory, oncology, ophthalmology, kidney disease, bone health, neurology, anticoagulants, antibiotics, diabetes, anti-anxiety, and many more.
